Del Carmen Jeffrey

CIK 00018164771 companyCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001816477

Recent Transactions

24 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2021-06-24+10,000→ 10,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2021-06-24−10,000→ 463,334 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2021-06-24−2,930→ 7,070 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2021-06-24−2,930→ 7,070 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2021-06-24−10,000→ 463,334 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2021-06-24+10,000→ 10,000 total

Companies

CATALYST PHARMACEUTICALS, INC.
Chief Commercial Officer
$CPRX

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov